WallStreetZenWallStreetZen

NASDAQ: KYMR
Kymera Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for KYMR

Based on 6 analysts offering 12 month price targets for Kymera Therapeutics Inc.
Min Forecast
$37.00+141.36%
Avg Forecast
$49.83+225.07%
Max Forecast
$85.00+454.47%

Should I buy or sell KYMR stock?

Based on 6 analysts offering ratings for Kymera Therapeutics Inc.
Buy
Strong Buy
2 analysts 33.33%
Buy
2 analysts 33.33%
Hold
2 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KYMR stock forecasts and price targets.

KYMR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Top 38%
63
HoldMaintains$37.00+141.36%2023-08-29
Stifel Nicolaus
Bottom 8%
8
Strong BuyMaintains$52.00+239.20%2023-08-07
Credit Suisse
Bottom 25%
25
HoldMaintains$37.00+141.36%2023-08-04
HC Wainwright & Co.
Bottom 1%
1
BuyReiterates$85.00+454.47%2023-08-04
Truist Securities
Bottom 6%
6
Strong BuyInitiates Coverage On$50.00+226.16%2023-06-30
Raymond James
Bottom 10%
10
BuyUpgrades$38.00+147.88%2023-05-05

1 of 1

Forecast return on equity

Is KYMR forecast to generate an efficient return?
Company
N/A
Industry
0.6%
Market
28.78%

Forecast return on assets

Is KYMR forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.1%

KYMR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KYMR$15.33$49.83+225.07%Buy
INVA$13.16$22.50+70.97%Strong Buy
PHVS$20.61$27.00+31.00%Strong Buy
VALN$12.06$22.00+82.42%Buy
INBX$19.86$31.00+56.09%Buy

Kymera Therapeutics Stock Forecast FAQ

Is Kymera Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: KYMR) stock is to Buy KYMR stock.

Out of 6 analysts, 2 (33.33%) are recommending KYMR as a Strong Buy, 2 (33.33%) are recommending KYMR as a Buy, 2 (33.33%) are recommending KYMR as a Hold, 0 (0%) are recommending KYMR as a Sell, and 0 (0%) are recommending KYMR as a Strong Sell.

If you're new to stock investing, here's how to buy Kymera Therapeutics stock.

What is KYMR's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: KYMR) forecast ROE is N/A, which is considered weak.

What is KYMR's Price Target?

According to 6 Wall Street analysts that have issued a 1 year KYMR price target, the average KYMR price target is $49.83, with the highest KYMR stock price forecast at $85.00 and the lowest KYMR stock price forecast at $37.00.

On average, Wall Street analysts predict that Kymera Therapeutics's share price could reach $49.83 by Aug 29, 2024. The average Kymera Therapeutics stock price prediction forecasts a potential upside of 225.07% from the current KYMR share price of $15.33.

What is KYMR's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: KYMR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.1%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.